207 related articles for article (PubMed ID: 21625236)
21. The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: novel drug targets with therapeutic potential?
Saftig P; Reiss K
Eur J Cell Biol; 2011; 90(6-7):527-35. PubMed ID: 21194787
[TBL] [Abstract][Full Text] [Related]
22. Recent advances on NOTCH signaling in T-ALL.
Tzoneva G; Ferrando AA
Curr Top Microbiol Immunol; 2012; 360():163-82. PubMed ID: 22673746
[TBL] [Abstract][Full Text] [Related]
23. ADAM10 is essential for proteolytic activation of Notch during thymocyte development.
Tian L; Wu X; Chi C; Han M; Xu T; Zhuang Y
Int Immunol; 2008 Sep; 20(9):1181-7. PubMed ID: 18635581
[TBL] [Abstract][Full Text] [Related]
24. TspanC8 tetraspanins regulate ADAM10/Kuzbanian trafficking and promote Notch activation in flies and mammals.
Dornier E; Coumailleau F; Ottavi JF; Moretti J; Boucheix C; Mauduit P; Schweisguth F; Rubinstein E
J Cell Biol; 2012 Oct; 199(3):481-96. PubMed ID: 23091066
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor-1 (IGF-1)-induced processing of amyloid-beta precursor protein (APP) and APP-like protein 2 is mediated by different metalloproteinases.
Jacobsen KT; Adlerz L; Multhaup G; Iverfeldt K
J Biol Chem; 2010 Apr; 285(14):10223-31. PubMed ID: 20139073
[TBL] [Abstract][Full Text] [Related]
26. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer.
Pruessmeyer J; Ludwig A
Semin Cell Dev Biol; 2009 Apr; 20(2):164-74. PubMed ID: 18951988
[TBL] [Abstract][Full Text] [Related]
27. ADAM10 as a target for anti-cancer therapy.
Moss ML; Stoeck A; Yan W; Dempsey PJ
Curr Pharm Biotechnol; 2008 Feb; 9(1):2-8. PubMed ID: 18289051
[TBL] [Abstract][Full Text] [Related]
28. The anti-malarial drug chloroquine sensitizes oncogenic NOTCH1 driven human T-ALL to γ-secretase inhibition.
Hounjet J; Habets R; Schaaf MB; Hendrickx TC; Barbeau LMO; Yahyanejad S; Rouschop KM; Groot AJ; Vooijs M
Oncogene; 2019 Jul; 38(27):5457-5468. PubMed ID: 30967635
[TBL] [Abstract][Full Text] [Related]
29. Surface expression and limited proteolysis of ADAM10 are increased by a dominant negative inhibitor of dynamin.
Carey RM; Blusztajn JK; Slack BE
BMC Cell Biol; 2011 May; 12():20. PubMed ID: 21586144
[TBL] [Abstract][Full Text] [Related]
30. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition.
Rapti M; Atkinson SJ; Lee MH; Trim A; Moss M; Murphy G
Biochem J; 2008 Apr; 411(2):433-9. PubMed ID: 18215140
[TBL] [Abstract][Full Text] [Related]
31. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
[TBL] [Abstract][Full Text] [Related]
32. The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events.
Moss ML; Bomar M; Liu Q; Sage H; Dempsey P; Lenhart PM; Gillispie PA; Stoeck A; Wildeboer D; Bartsch JW; Palmisano R; Zhou P
J Biol Chem; 2007 Dec; 282(49):35712-21. PubMed ID: 17895248
[TBL] [Abstract][Full Text] [Related]
33. Ligand-activated Notch undergoes DTX4-mediated ubiquitylation and bilateral endocytosis before ADAM10 processing.
Chastagner P; Rubinstein E; Brou C
Sci Signal; 2017 Jun; 10(483):. PubMed ID: 28611181
[TBL] [Abstract][Full Text] [Related]
34. A conserved tetraspanin subfamily promotes Notch signaling in Caenorhabditis elegans and in human cells.
Dunn CD; Sulis ML; Ferrando AA; Greenwald I
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5907-12. PubMed ID: 20220101
[TBL] [Abstract][Full Text] [Related]
35. ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha.
Le Gall SM; Bobé P; Reiss K; Horiuchi K; Niu XD; Lundell D; Gibb DR; Conrad D; Saftig P; Blobel CP
Mol Biol Cell; 2009 Mar; 20(6):1785-94. PubMed ID: 19158376
[TBL] [Abstract][Full Text] [Related]
36. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
37. Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and γ-secretase.
Hogl S; Kuhn PH; Colombo A; Lichtenthaler SF
PLoS One; 2011; 6(6):e21337. PubMed ID: 21695060
[TBL] [Abstract][Full Text] [Related]
38. Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and gamma-secretase inhibitors.
Silva A; Jotta PY; Silveira AB; Ribeiro D; Brandalise SR; Yunes JA; Barata JT
Haematologica; 2010 Apr; 95(4):674-8. PubMed ID: 20015880
[TBL] [Abstract][Full Text] [Related]
39. The cytoplasmic domain of a disintegrin and metalloproteinase 10 (ADAM10) regulates its constitutive activity but is dispensable for stimulated ADAM10-dependent shedding.
Maretzky T; Evers A; Le Gall S; Alabi RO; Speck N; Reiss K; Blobel CP
J Biol Chem; 2015 Mar; 290(12):7416-25. PubMed ID: 25605720
[TBL] [Abstract][Full Text] [Related]
40. SFRPs act as negative modulators of ADAM10 to regulate retinal neurogenesis.
Esteve P; Sandonìs A; Cardozo M; Malapeira J; Ibañez C; Crespo I; Marcos S; Gonzalez-Garcia S; Toribio ML; Arribas J; Shimono A; Guerrero I; Bovolenta P
Nat Neurosci; 2011 May; 14(5):562-9. PubMed ID: 21478884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
